Disease‐modifying treatments for multiple sclerosis – a review of approved medications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Disease‐modifying treatments for multiple sclerosis – a review of approved medications

Published:2015-11-13 Issue:S1 Volume:23 Page:18-27
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Torkildsen Ø.¹²,Myhr K.‐M.¹³,Bø L.¹²

Affiliation:

1. Department of Clinical Medicine KG Jebsen MS Research Centre University of Bergen BergenNorway

2. Department of Neurology Norwegian Multiple Sclerosis Competence Centre Haukeland University Hospital BergenNorway

3. Department of Neurology Norwegian Multiple Sclerosis Registry and Biobank Haukeland University Hospital Bergen Norway

Funder

Genzyme

Novartis

Biogen Idec

Bayer

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.12883

Reference71 articles.

1. Axonal Transection in the Lesions of Multiple Sclerosis

2. The window of therapeutic opportunity in multiple sclerosis

3. Multiple sclerosis: Prospects and promise

4. Freedom from disease activity in multiple sclerosis

5. Interferon‐β mechanisms of action in multiple sclerosis;Dhib‐Jalbut S;Neurology,2010

Cited by 244 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer and Autoimmune Diseases as Two Sides of Chronic Inflammation and the Method of Therapy;Current Cancer Drug Targets;2024-11

2. How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?;American Economic Journal: Economic Policy;2024-08-01

3. Characterization of pathological stages in a mouse model of progressive multiple sclerosis;Neuroscience Research;2024-07

4. Adherence to treatment in multiple sclerosis: case reports of three female patients on high-efficacy therapy with ocrelizumab;Neurologie pro praxi;2024-06-20

5. Optimizing drug therapy for older adults: shifting away from problematic polypharmacy;Expert Opinion on Pharmacotherapy;2024-06-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3